Eighteen Years of Fair Glycemic Control Preserves Cardiac Autonomic Function in Type 1 Diabetes

Diabetes Care

Volumn 27, Issue 4, 2004, Pages 963-966

  Larsen, Jakob R ^a   Sjøholm, Hans ^a   Berg, Tore J ^b   Sandvik, Leiv ^a   Brekke, Magne ^a   Hanssen, Kristian F ^a,b   Dahl Jørgensen, Knut ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CONTROLLED STUDY; DIABETIC NEUROPATHY; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HEART RATE VARIABILITY; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADULT; AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; HEART; HEART FUNCTION TESTS; HEART RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RESPIRATORY MECHANICS; TILT-TABLE TEST;

EID: 1842433634     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.4.963     Document Type: Article

References (24)

1. O'Brien IA, McFadden JP, Corrall RJ: The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. QJ Med 79:495-502, 1991
2. Orchard TJ, Stevens LK, Forrest KY, Fuller JH: Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe 9. Int J Epidemiol 27:976-983, 1998
3. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793-1798, 2001
4. Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 26:1895-1901, 2003
5. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 41:416-423, 1998
6. Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, Hanssen KF: The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 37:579-584, 1994
7. Vinik AI, Erbas T: Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928-944, 2001
8. Larsen JR, Sjoholm H, Hanssen KF, Sandvik L, Berg TJ, Dahl-Jorgensen K : Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes. Diabetes Care 26:2400-2404, 2003
9. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy (Review). Diabetes Care 26:1553-1579, 2003
10. Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev 10:339-383, 1994
11. Riihimaa PH, Suominen K, Knip M, Tapanainen P, Tolonen U: Cardiovascular autonomic reactivity is decreased in adolescents with type 1 diabetes. Diabet Med 19:932-938, 2002
12. Dahl-Jorgensen K: Near-normoglycemia and late diabetic complications: the Oslo Study. Acta Endocrinol Suppl (Copenh) 284:1-38, 1987
13. Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K: Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637-2641, 2002
14. Stalberg EV, Nogues MA: Automatic analysis of heart rate variation. I: method and reference values in healthy controls. Muscle Nerve 12:993-1000, 1989
15. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. Br Med J 285:916-918, 1982
16. Nordenfeldt I, Adolfsson L, Nilsson JE, and Olsson S: Reference values for exercise test with continuous increase in load. Clin Physiol 5:161-172, 1985
17. Reichard P, Jensen-Urstad K, Ericsson M, Jensen-Urstad M, Lindblad LE: Autonomic neuropathy - a complication less pronounced in patients with type 1 diabetes mellitus who have lower blood glucose levels. Diabet Med 17:860-866, 2000
18. Chamari K, Moussa-Chamari I, Galy O, Chaouachi M, Koubaa D, Hassen CB, Hue O: Correlation between heart rate and performance during Olympic windsurfing competition. Eur J Appl Physiol 89:387-392, 2003
19. Kahn JK, Zola B, Juni JE, Vinik AI: Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care 9:389-394, 1986
20. Howorka K, Pumprla J, Haber P, Koller-Strametz J, Mondrzyk J, Schabmann A: Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res 34:206-214, 1997
21. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322:15-18, 2001
22. Krantz JS, Kaufman FR, Hodis H, Liu C, Halvorson M: Increased atherosclerosis, measured by carotid artery IMT (CCA IMT), in 12-21 year olds with type 1 diabetes (Abstract). Diabetes 50:A158, 2001
23. Liao D, Carnethon M, Evans G, Cascio W, Heiss G: Lower heart rate variability is associated with the development of coronary heart disease in diabetics: the ARIC study. Am J Epidemiol 151:S35, 2000
24. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001